Trial record 1 of 1 for:    reach2hd
Previous Study | Return to List | Next Study

Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease (Reach2HD)

This study has been completed.
Information provided by (Responsible Party):
Prana Biotechnology Limited Identifier:
First received: April 18, 2012
Last updated: February 9, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
No publications provided by Prana Biotechnology Limited

Publications automatically indexed to this study by Identifier (NCT Number):